Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1203260-55-2 | MDL No. : | MFCD04038557 |
Formula : | C13H19ClN2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | RAIJBIOKQJMHNV-UHFFFAOYSA-N |
M.W : | 270.76 | Pubchem ID : | 23024282 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.46 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 76.29 |
TPSA : | 50.36 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.28 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 2.36 |
Log Po/w (WLOGP) : | 1.93 |
Log Po/w (MLOGP) : | 1.68 |
Log Po/w (SILICOS-IT) : | 1.65 |
Consensus Log Po/w : | 1.52 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.92 |
Solubility : | 0.324 mg/ml ; 0.0012 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.06 |
Solubility : | 0.237 mg/ml ; 0.000876 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.76 |
Solubility : | 0.0472 mg/ml ; 0.000174 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.77 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
[ 478646-32-1 ]
(R)-Benzyl piperidin-3-ylcarbamate
Similarity: 0.98
[ 1217652-74-8 ]
(R)-Benzyl (pyrrolidin-2-ylmethyl)carbamate hydrochloride
Similarity: 0.97
[ 1179361-76-2 ]
2-N-Cbz-Butane-1,2-diamine hydrochloride
Similarity: 0.95
[ 1217631-74-7 ]
(S)-Benzyl pyrrolidin-3-ylcarbamate hydrochloride
Similarity: 0.93
[ 960541-42-8 ]
Benzyl 3-aminopiperidine-1-carboxylate hydrochloride
Similarity: 0.92
[ 478646-32-1 ]
(R)-Benzyl piperidin-3-ylcarbamate
Similarity: 0.98
[ 1217652-74-8 ]
(R)-Benzyl (pyrrolidin-2-ylmethyl)carbamate hydrochloride
Similarity: 0.97
[ 1179361-76-2 ]
2-N-Cbz-Butane-1,2-diamine hydrochloride
Similarity: 0.95
[ 1217631-74-7 ]
(S)-Benzyl pyrrolidin-3-ylcarbamate hydrochloride
Similarity: 0.93
[ 960541-42-8 ]
Benzyl 3-aminopiperidine-1-carboxylate hydrochloride
Similarity: 0.92
[ 478646-32-1 ]
(R)-Benzyl piperidin-3-ylcarbamate
Similarity: 0.98
[ 1217652-74-8 ]
(R)-Benzyl (pyrrolidin-2-ylmethyl)carbamate hydrochloride
Similarity: 0.97
[ 1179361-76-2 ]
2-N-Cbz-Butane-1,2-diamine hydrochloride
Similarity: 0.95
[ 1217631-74-7 ]
(S)-Benzyl pyrrolidin-3-ylcarbamate hydrochloride
Similarity: 0.93
[ 960541-42-8 ]
Benzyl 3-aminopiperidine-1-carboxylate hydrochloride
Similarity: 0.92
[ 478646-32-1 ]
(R)-Benzyl piperidin-3-ylcarbamate
Similarity: 0.98
[ 1217652-74-8 ]
(R)-Benzyl (pyrrolidin-2-ylmethyl)carbamate hydrochloride
Similarity: 0.97
[ 876378-16-4 ]
(S)-Benzyl 3-aminopiperidine-1-carboxylate hydrochloride
Similarity: 0.92
[ 960541-42-8 ]
Benzyl 3-aminopiperidine-1-carboxylate hydrochloride
Similarity: 0.92
[ 478646-32-1 ]
(R)-Benzyl piperidin-3-ylcarbamate
Similarity: 0.98
[ 876378-16-4 ]
(S)-Benzyl 3-aminopiperidine-1-carboxylate hydrochloride
Similarity: 0.92
[ 960541-42-8 ]
Benzyl 3-aminopiperidine-1-carboxylate hydrochloride
Similarity: 0.92
[ 1044560-96-4 ]
(R)-Benzyl 3-aminopiperidine-1-carboxylate
Similarity: 0.90